← Eichor
Condition: Underweight Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Underweight

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa
Phase N/A · 1 location(s) · Swiss Tropical & Public Health Institute · NCT05881447
Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight Infants
NA · 24 location(s) · Nationwide Children's Hospital · NCT05547165
Population Pharmacokinetics of Remifentanil in Low-Weight Critically Ill Patients
Phase N/A · 1 location(s) · Fudan University · NCT07301970
Effectiveness of Small-Quantity vs Medium-Quantity Lipid-Based Nutrient Supplements for Prevention of Undernutrition in
NA · 2 location(s) · Aga Khan University · NCT07451951
Efficacy of Non-invasive Vagus Nerve Stimulation for Treatment of Low Weight Eating Disorders
NA · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT05554172
Experimental Approach to Test Predictions of Body Weight Regulation Models
NA · 1 location(s) · Pennington Biomedical Research Center · NCT06309576
Management of Shock in Children With SAM or Severe Underweight and Diarrhea
Phase 3 · 1 location(s) · International Centre for Diarrhoeal Disease Research, Bangla · NCT04750070
Interoceptive Exposure for Adolescents With Low Weight Eating Disorders
NA · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT05763849
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.